Time-sequential changes of differentially expressed miRNAs during the process of anterior lumbar interbody fusion using equine bone protein extract, rhBMP-2 and autograft
Da-Fu CHEN, Zhi-Yu ZHOU, Xue-Jun DAI, Man-Man GAO, Bao-Ding HUANG, Tang-Zhao LIANG, Rui SHI, Li-Jin ZOU, Hai-Sheng LI, Cody BÜNGER, Wei TIAN, Xue-Nong ZOU
Time-sequential changes of differentially expressed miRNAs during the process of anterior lumbar interbody fusion using equine bone protein extract, rhBMP-2 and autograft
The precise mechanism of bone regeneration in different bone graft substitutes has been well studied in recent researches. However, miRNAs regulation of the bone formation has been always mysterious. We developed the anterior lumbar interbody fusion (ALIF) model in pigs using equine bone protein extract (BPE), recombinant human bone morphogenetic protein-2 (rhBMP-2) on an absorbable collagen sponge (ACS), and autograft as bone graft substitute, respectively. The miRNA and gene expression profiles of different bone graft materials were examined using microarray technology and data analysis, including self-organizing maps, KEGG pathway and Biological process GO analyses. We then jointly analyzed miRNA and mRNA profiles of the bone fusion tissue at different time points respectively. Results showed that miRNAs, including let-7, miR-129, miR-21, miR-133, miR-140, miR-146, miR-184, and miR-224, were involved in the regulation of the immune and inflammation response, which provided suitable inflammatory microenvironment for bone formation. At late stage, several miRNAs directly regulate SMAD4, Estrogen receptor 1 and 5-hydroxytryptamine (serotonin) receptor 2C for bone formation. It can be concluded that miRNAs play important roles in balancing the inflammation and bone formation.
miRNA / bone protein extract (BPE) / recombinant human bone morphogenetic protein-2 (rhBMP-2) / autograft
[1] |
Hobert O. Gene regulation by transcription factors and microRNAs. Science, 2008, 319(5871): 1785–1786
|
[2] |
Lian J B, Stein G S, van Wijnen A J,
|
[3] |
Palmieri A, Pezzetti F, Brunelli G,
|
[4] |
Palmieri A, Pezzetti F, Avantaggiato A,
|
[5] |
Palmieri A, Brunelli G, Guerzoni L,
|
[6] |
Palmieri A, Pezzetti F, Brunelli G,
|
[7] |
Palmieri A, Pezzetti F, Brunelli G,
|
[8] |
Palmieri A, Pezzetti F, Spinelli G,
|
[9] |
Palmieri A, Pezzetti F, Brunelli G,
|
[10] |
Palmieri A, Pezzetti F, Brunelli G,
|
[11] |
Palmieri A, Pezzetti F, Brunelli G,
|
[12] |
Palmieri A, Pezzetti F, Brunelli G,
|
[13] |
Foldager C, Bendtsen M, Zou X,
|
[14] |
Li H, Zou X, Woo C,
|
[15] |
Zou X, Zou L, Foldager C,
|
[16] |
Saeed A I, Sharov V, White J,
|
[17] |
Mountziaris P M, Spicer P P, Kasper F K,
|
[18] |
Mountziaris P M, Mikos A G. Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Engineering Part B: Reviews, 2008, 14(2): 179–186
|
[19] |
Kolar P, Schmidt-Bleek K, Schell H,
|
[20] |
Takayanagi H. Osteoimmunology and the effects of the immune system on bone. Nature Reviews Rheumatology, 2009, 5(12): 667–676
|
[21] |
Pape H C, Marcucio R, Humphrey C,
|
[22] |
Rodig S J, Shahsafaei A, Li B,
|
[23] |
Koarai A, Traves S L, Fenwick P S,
|
[24] |
Koarai A, Yanagisawa S, Sugiura H,
|
[25] |
Miwa T, Zhou L, Maldonado M A,
|
[26] |
Kalland M E, Oberprieler N G, Vang T,
|
[27] |
Rouault C, Pellegrinelli V, Schilch R,
|
[28] |
Chou J, Werb Z. MicroRNAs play a big role in regulating ovarian cancer-associated fibroblasts and the tumor microenvironment. Cancer Discovery, 2012, 2(12): 1078–1080
|
[29] |
Melo S A, Kalluri R. miR-29b moulds the tumour microenvironment to repress metastasis. Nature Cell Biology, 2013, 15(2): 139–140
|
[30] |
Chou J, Lin J H, Brenot A,
|
[31] |
Tural S, Kara N, Alayli G,
|
[32] |
Lindahl K, Rubin C J, Brändström H,
|
[33] |
Narisawa S, Yadav M C, Millán J L. In vivo overexpression of tissue-nonspecific alkaline phosphatase increases skeletal minera-lization and affects the phosphorylation status of osteopontin. Journal of Bone and Mineral Research, 2013, 28(7): 1587–1598
|
[34] |
Kapinas K, Kessler C, Ricks T,
|
[35] |
Li Z, Hassan M Q, Jafferji M,
|
[36] |
Kamiya N, Kobayashi T, Mochida Y,
|
[37] |
Kamiya N, Ye L, Kobayashi T,
|
[38] |
Guo X, Day T F, Jiang X,
|
[39] |
Zhang J, He X C, Tong W G,
|
[40] |
He X C, Zhang J, Tong W G,
|
[41] |
Li J, Huang X, Xu X,
|
[42] |
Zhang H, Sucato D J, Welch R D. Recombinant human bone morphogenic protein-2-enhanced anterior spine fusion without bone encroachment into the spinal canal: a histomorphometric study in a thoracoscopically instrumented porcine model. Spine, 2005, 30(5): 512–518
|
[43] |
Damien C J, Grob D, Boden S D,
|
[44] |
Sandhu H S, Khan S N. Animal models for preclinical assessment of bone morphogenetic proteins in the spine. Spine, 2002, 27(16S): S32–S38
|
[45] |
Minamide A, Yoshida M, Kawakami M,
|
[46] |
Kandziora F, Pflugmacher R, Scholz M,
|
[47] |
Burks M V, Nair L. Long-term effects of bone morphogenetic protein-based treatments in humans. Journal of Long-Term Effects of Medical Implants, 2010, 20(4): 277–293
|
/
〈 | 〉 |